Regular CBD use and the body's response to acute stress
Official title: Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms
Run by University of Minnesota · NCT07069478 · Data updated 2026-11-12
This study will test whether adults who use cannabidiol (CBD) regularly have different physical and mood reactions to an acute stress test compared with adults who do not use CBD.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 70 Years |
| Sex | All |
| Enrollment | 125 (estimated) |
| Sponsor | University of Minnesota Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Status | Recruiting |
| Started | June 16, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2028 |
| Registry record updated | July 22, 2026 |
| Trial ID | NCT07069478 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy adults aged 21–70 who either use CBD daily/regularly or do not use CBD regularly and who can maintain a normal night-time sleep schedule are ideal candidates.
✕Probably not a fit
People with unstable major psychiatric or medical conditions, current illicit substance use (other than cannabis), self-reported pregnancy, or inability to follow pre-visit abstinence rules are excluded and unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will compare psychobiological responses to an acute laboratory stressor between relatively healthy adults aged 21–70 who either use CBD regularly or do not. The protocol includes measurement of cardiovascular reactivity, hypothalamic-pituitary-adrenal (HPA) axis markers, and mood responses before, during, and after stress induction. Correlates of CBD use such as tobacco use and basic health screening will be collected to help interpret findings. Participants must attend visits at the University of Minnesota and follow pre-visit abstinence and sleep schedule instructions.
Why it matters
Potential benefit: If successful, the findings could clarify whether regular CBD use changes physiological or mood responses to stress and inform guidance for people using CBD for stress management.
How similar studies have gone: Some single-dose laboratory studies of CBD have reported reduced anxiety or altered stress markers, but evidence on effects of regular CBD use on physiological stress responses is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults who are relatively healthy and aged 21-70 years. * Must keep a normal sleep schedule (sleep during nighttime, awake during daytime). * Must either (1) use CBD daily/regularly or (2) not use CBD regularly. Exclusion Criteria: * Participated in previous acute stress studies that included a similar stress induction. * Current, unstable: major psychiatric disorder or medical condition (e.g., uncontrolled hypertension above 160/100). * Self-reported current pregnancy. * Self-reported current use of illicit substances (other than cannabis). * Non-compliance with instructions for study visit (abstinence from alcohol, caffeine, physical activity, etc.) * Students of the principal researcher
Where it's running
-
University of Minnesota
Minneapolis, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Mustafa al'Absi — University of Minnesota
- Study coordinator: Stress and Resilience Research Labs
- Email: umdbml@d.umn.edu
- Phone: 2187268623
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Vitamin D to Help Maintain Cognitive and Physical Performance Under Stress
This study tests whether daily vitamin D helps healthy adults keep their thinking and simple physical tasks steady and their mood stable during highly stressful lab conditions.
-
Cannabidiol (CBD) for reducing stress and nicotine withdrawal in daily cigarette smokers.
This trial tests whether a single dose of CBD can reduce stress responses and nicotine withdrawal symptoms in adults who smoke cigarettes daily.
-
Effects of medications on performance after spider exposure
This study is testing whether three different medications can help people with a fear of spiders perform better after experiencing a stressful situation.
-
BXCL501 given shortly after a car crash to reduce acute stress and later PTSD symptoms
This will test whether a short course of BXCL501 sublingual film given in the emergency department after a motor vehicle collision can reduce acute stress symptoms and lower the chance of developing PTSD in high‑risk adults.
-
Using TNX-102 SL to reduce acute stress reactions after motor vehicle collisions
This study is testing if a new medication can help people who have just been in a car accident feel less stressed and prevent long-term trauma symptoms.
-
Intervention to help people cope with acute stress reactions
This study tests a new quick support method called iCOVER to help people dealing with acute stress reactions feel better and get back to normal after a stressful event.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.